These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 7883660

  • 1. Experience with amphotericin B in sodium stibogluconate--unresponsive cases of visceral Leishmaniasis in north Bihar.
    Giri OP, Singh AN.
    J Assoc Physicians India; 1994 Sep; 42(9):690-1. PubMed ID: 7883660
    [Abstract] [Full Text] [Related]

  • 2. Magnitude of unresponsiveness to sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar.
    Das VN, Ranjan A, Bimal S, Siddique NA, Pandey K, Kumar N, Verma N, Singh VP, Sinha PK, Bhattacharya SK.
    Natl Med J India; 2005 Sep; 18(3):131-3. PubMed ID: 16130613
    [Abstract] [Full Text] [Related]

  • 3. Amphotericin B therapy in kala-azar.
    Giri OP.
    J Indian Med Assoc; 1993 Apr; 91(4):91-3. PubMed ID: 8409490
    [Abstract] [Full Text] [Related]

  • 4. Amphotericin B in resistant kala-azar in Bihar.
    Thakur CP, Sinha GP, Pandey AK, Barat D, Sinha PK.
    Natl Med J India; 1993 Apr; 6(2):57-60. PubMed ID: 8477209
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of amphotericin B as a first line drug in comparison to sodium stibogluconate in the treatment of fresh cases of kala-azar.
    Thakur CP, Sinha GP, Sharma V, Pandey AK, Kumar M, Verma BB.
    Indian J Med Res; 1993 Jul; 97():170-5. PubMed ID: 8406644
    [Abstract] [Full Text] [Related]

  • 6. Amphotericin versus sodium stibogluconate in first-line treatment of Indian kala-azar.
    Mishra M, Biswas UK, Jha AM, Khan AB.
    Lancet; 1994 Dec 10; 344(8937):1599-600. PubMed ID: 7983993
    [Abstract] [Full Text] [Related]

  • 7. Comparison of treatment regimens of kala-azar based on culture & sensitivity of amastigotes to sodium antimony gluconate.
    Thakur CP, Thakur S, Narayan S, Sinha A.
    Indian J Med Res; 2008 Jun 10; 127(6):582-8. PubMed ID: 18765878
    [Abstract] [Full Text] [Related]

  • 8. A thirty day course of sodium stibogluconate for treatment of Kala-azar in Nepal.
    Karki P, Koirala S, Parija SC, Hansdak SG, Das ML.
    Southeast Asian J Trop Med Public Health; 1998 Mar 10; 29(1):154-8. PubMed ID: 9740292
    [Abstract] [Full Text] [Related]

  • 9. Observations on amphotericin B treatment of kala-azar given in a rural set up in Bihar, India.
    Thakur CP, Ahmed S.
    Indian J Med Res; 2001 Jan 10; 113():14-8. PubMed ID: 11280166
    [Abstract] [Full Text] [Related]

  • 10. Treatment of visceral Leishmaniasis unresponsive to pentamidine with amphotericin B.
    Giri OP.
    J Assoc Physicians India; 1994 Sep 10; 42(9):688-9. PubMed ID: 7883659
    [Abstract] [Full Text] [Related]

  • 11. Observations on the effect of verapamil with sodium stibogluconate in kala azar.
    Thakur CP, Kumar M.
    Trop Geogr Med; 1992 Jan 10; 44(1-2):15-8. PubMed ID: 1323160
    [Abstract] [Full Text] [Related]

  • 12. Epidemiological, clinical & pharmacological study of antimony-resistant visceral leishmaniasis in Bihar, India.
    Thakur CP, Narayan S, Ranjan A.
    Indian J Med Res; 2004 Sep 10; 120(3):166-72. PubMed ID: 15489554
    [Abstract] [Full Text] [Related]

  • 13. [A case of antimony resistant kala-azar cured with amphotericin B].
    Chen SB, Yang CM, Zhang CJ.
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Jun 10; 25(3):inside front page. PubMed ID: 18038767
    [No Abstract] [Full Text] [Related]

  • 14. Cumulative cardiac toxicity of sodium stibogluconate and amphotericin B in treatment of kala-azar.
    Maheshwari A, Seth A, Kaur S, Aneja S, Rath B, Basu S, Patel R, Dutta AK.
    Pediatr Infect Dis J; 2011 Feb 10; 30(2):180-1. PubMed ID: 20823781
    [Abstract] [Full Text] [Related]

  • 15. A retrospective study of intravenous sodium stibogluconate alone and in combinations with allopurinol, rifampicin, and an immunomodulator in the treatment of Indian post-kala-azar dermal leishmaniasis.
    Ramesh V, Kumar J, Kumar D, Salotra P.
    Indian J Dermatol Venereol Leprol; 2010 Feb 10; 76(2):138-44. PubMed ID: 20228542
    [Abstract] [Full Text] [Related]

  • 16. A comparison of liposomal amphotericin B with sodium stibogluconate for the treatment of visceral leishmaniasis in pregnancy in Sudan.
    Mueller M, Balasegaram M, Koummuki Y, Ritmeijer K, Santana MR, Davidson R.
    J Antimicrob Chemother; 2006 Oct 10; 58(4):811-5. PubMed ID: 16916865
    [Abstract] [Full Text] [Related]

  • 17. A kala-azar control programme for remote tribal communities.
    Thakur CP, Frances Sister, Therese Sister, Victoria Sister, Puspa Sister.
    World Health Forum; 1994 Oct 10; 15(3):245-7. PubMed ID: 7945751
    [Abstract] [Full Text] [Related]

  • 18. Safety of a pre-formulated amphotericin B lipid emulsion for the treatment of Indian Kala-azar.
    Sundar S, Chakravarty J, Agarwal D, Shah A, Agrawal N, Rai M.
    Trop Med Int Health; 2008 Sep 10; 13(9):1208-12. PubMed ID: 18664241
    [Abstract] [Full Text] [Related]

  • 19. Sodium stibogluconate-sensitive visceral leishmaniasis in the non-endemic hilly region of Uttarakhand, India.
    Verma SK, Ahmad S, Shirazi N, Kusum A, Kaushik RM, Barthwal SP.
    Trans R Soc Trop Med Hyg; 2007 Jul 10; 101(7):730-2. PubMed ID: 17382981
    [Abstract] [Full Text] [Related]

  • 20. Amphotericin versus pentamidine in antimony-unresponsive kala-azar.
    Mishra M, Biswas UK, Jha DN, Khan AB.
    Lancet; 1992 Nov 21; 340(8830):1256-7. PubMed ID: 1359322
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.